A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance

NCT ID: NCT07183735 Phase: NA Status: COMPLETED Enrollment: 40 Completion: 2024-10-17

Conditions

Sleep, Sleep Disorder

Interventions

BEAM Dream Powder, Placebo Control

Summary

This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.

Primary Outcome

Change in sleep quality as measured by the Sleep Quality Scale (SQS)

Source

ClinicalTrials.gov